Contact Us
Thank you for choosing Dermatology Times as your trusted resource. Together, we are advancing the science of skin health and enhancing the lives of patients worldwide. We value you and your feedback. Whether you have questions, suggestions, or topics you would like us to cover, we encourage you to reach out to us via email at
For general inquiries:
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
5

